This broad and very complex interaction between uPA, PAI-1, and dCK+ cells could explain the observed additive and maybe even synergistic effects of those three factors regarding outcomes of patients in early breast cancer stages. The gene discussed is SERPINE1; the disease is breast carcinoma.